If you used chemical hair relaxers regularly over a period of years and were later diagnosed with uterine or ovarian cancer, you can still join the hair relaxer lawsuit pending in federal court in Chicago. More than 11,500 cases are consolidated there, no settlements have been paid yet, and the single most important ruling in the litigation is expected after briefing closes in November 2026. Your filing deadline depends on your state and on when you reasonably connected your diagnosis to relaxer use, and for many potential plaintiffs that window is closing now.
Who Can File a Claim
Eligibility turns on two things: your diagnosis and how often you used chemical relaxers. The litigation primarily targets uterine cancer and ovarian cancer, the conditions most strongly supported by the epidemiological evidence. Within those categories, endometrial adenocarcinoma, uterine sarcoma, and various ovarian malignancies are the strongest claims.
Attorneys screening cases generally look for a pattern of regular use, at least four or more times per year over several years. That threshold mirrors the definition of frequent use in the 2022 Sister Study published in the Journal of the National Cancer Institute, which found that women who used hair straightening products more than four times in the prior year had more than double the rate of uterine cancer, with a hazard ratio of 2.55.1Oxford University Press. Use of Straighteners and Other Hair Products and Incident Uterine Cancer Women who had ever used the products in the prior year had an 80% higher rate than women who never used them. Your diagnosis also needs to have come after a meaningful period of product use.
Plaintiffs allege that endocrine-disrupting chemicals in relaxer formulations drive the risk. These include phthalates, parabens, and formaldehyde or formaldehyde-releasing compounds like methylene glycol. The theory is that these chemicals mimic estrogen after absorption through the scalp, with the heat applied during relaxer treatments increasing absorption. The FDA proposed banning formaldehyde and formaldehyde-releasing chemicals in hair straighteners, but as of early 2026 the agency has repeatedly missed its own deadlines and no federal ban is in effect.
Uterine Fibroids and Other Non-Cancer Conditions
Fibroids are a more complicated story. Some firms are signing up fibroid cases, and the official Plaintiff Fact Sheet asks whether plaintiffs have been diagnosed with fibroids. But the MDL is structured around cancer claims, and fibroid cases have not been prioritized the same way. If you developed fibroids after prolonged relaxer use, it is worth consulting an attorney, but expect lower estimated values and greater uncertainty than cancer-based cases.
Brands and Manufacturers Named
Several major cosmetic companies are defendants. L’Oréal and its subsidiary SoftSheen-Carson are among the most prominent, along with Namaste Laboratories. Revlon is also named, though its ongoing bankruptcy adds a wrinkle: claims against Revlon can only be filed directly in the MDL, consistent with the bankruptcy court’s order.2United States District Court Northern District of Illinois. MDL 3060 Best Practices and Frequently Asked Questions Product lines appearing frequently in complaints include Dark & Lovely, Optimum, and Motion.
The central legal theory is failure to warn. Plaintiffs argue that manufacturers knew or should have known about the cancer risks associated with the chemicals in their products and failed to alert consumers. By marketing these products as safe for regular use, and in many cases marketing them specifically to Black women, the companies allegedly prioritized sales over safety.
Filing Deadlines Are Tightening
Every state has its own statute of limitations for product liability claims, and failing to file before your deadline expires means losing your right to sue entirely. Most states give you somewhere between two and four years, though some allow longer. The clock does not necessarily start when you first used the product. In most states a discovery rule applies, meaning the limitations period begins when you knew or reasonably should have known that your injury was connected to hair relaxer use.
For many potential plaintiffs, the November 2022 publication of the Sister Study is the pivotal date. If that study was the first time you had reason to connect your cancer diagnosis to relaxer use, courts in many jurisdictions could treat it as the starting point. Under a two-year limitations period, that window has already closed. Under a three-year period, it closes in late 2025. The math is getting tight for anyone who has not filed yet.
How to File in MDL 3060
The cases are consolidated as Multi-District Litigation No. 3060 in the U.S. District Court for the Northern District of Illinois before Judge Mary Rowland. You can file a lawsuit in any federal court and have it transferred to the Northern District of Illinois, or you can file directly in that district under the terms of Case Management Order No. 2.2United States District Court Northern District of Illinois. MDL 3060 Best Practices and Frequently Asked Questions Most new claimants file directly. The case is filed as a new action with a civil cover sheet noting the relationship to master docket number 23-cv-0818 and MDL 3060. The standard federal filing fee of $402 applies.
Every directly filed case must include a Short Form Complaint rather than a full-length lawsuit.2United States District Court Northern District of Illinois. MDL 3060 Best Practices and Frequently Asked Questions This streamlined document incorporates the common allegations from the master case, and your attorney fills in the details specific to your claim. The court has warned that plaintiffs who fail to properly serve their Short Form Complaints risk having their cases dismissed permanently.
After filing, you complete the Plaintiff Fact Sheet, which functions as a sworn statement. Your answers carry the same legal weight as responses to formal discovery requests. Providing false or incomplete information can damage your case or lead to sanctions.
Documentation You Will Need
A strong claim requires records from two parts of your life: your medical history and your product use history. Start gathering these early, because gaps in documentation are one of the most common reasons cases stall.
Medical Records
Pathology reports confirming your cancer diagnosis are the single most important document. You will also need surgical summaries, treatment records, and imaging or lab work tracking the progression of the disease. Request these directly from the hospitals and oncology clinics where you received care. The Plaintiff Fact Sheet requires detailed information about each injury, the date of diagnosis, the diagnosing provider, and every type of treatment you received along with dates and treating providers.
The fact sheet also asks about your broader medical history, including conditions like endometriosis, breast cancer, high estrogen levels, polycystic ovarian syndrome, and diabetes. It asks about reproductive history, including pregnancies, menstrual patterns, menopause, hormone replacement therapy, and genetic testing for BRCA1 and BRCA2 mutations. Defendants will scrutinize whether other risk factors contributed to your diagnosis.
Product Use History
Identifying the specific brands you used matters, because each manufacturer is a separate defendant. Think through where you purchased products and check whether any of those retailers keep records. If you had relaxers applied at a salon, contact the salon to request service logs or appointment records. The fact sheet asks for each product’s brand name, dates of use, how often you used it, and whether you applied it at home or at a salon. You will also need to disclose other chemical hair products you used frequently, including keratin treatments, Brazilian blowouts, and hair dyes.
Financial Records for Damages
To support the economic side of your claim, gather records of out-of-pocket medical costs, insurance statements showing what was billed and paid, and evidence of lost income. If you missed work during treatment, collect pay stubs from before and after your diagnosis, along with documentation from your employer confirming the time missed. Self-employed claimants should compile tax returns, profit and loss statements, and bank records showing the drop in income. Less obvious losses count too, including retirement contributions your employer stopped making and bonuses you missed during treatment.
Where the Litigation Stands in 2026
As of mid-2026, roughly 11,500 individual cases are pending in MDL 3060. The litigation is in its expert discovery phase, and the most consequential event on the horizon is the Daubert ruling, a judicial decision on whether the plaintiffs’ scientific experts will be allowed to testify at trial.
A Science Day hearing was held on January 8, 2026, where both sides presented their positions on general causation, essentially whether hair relaxer chemicals can cause cancer at all. Defendants filed formal Daubert motions by April 1, 2026, challenging the admissibility of testimony from the plaintiffs’ ten expert witnesses. Oppositions were due May 1, with reply briefs due May 15. The deadline for summary judgment and remaining expert challenges is November 16, 2026. Defendants have been allocated up to 100 pages of briefing to challenge the plaintiffs’ experts, an unusually generous allowance.
If the court finds the plaintiffs’ expert testimony scientifically reliable and admissible, bellwether trials are expected in 2027. Those outcomes will heavily influence whether manufacturers negotiate a global settlement and at what dollar amounts. If key experts are excluded, the entire litigation could stall or collapse. No bellwether trials have occurred yet, and no settlements have been reached.
What Cases Might Be Worth
Because no settlements have been paid, any dollar figures are projections based on injury severity, comparable mass tort outcomes, and assumptions about the Daubert hearings. Legal analysts have offered a wide range of estimates. Cases involving uterine or ovarian cancer diagnoses with aggressive treatment histories could potentially reach several hundred thousand dollars to over a million. Cases involving uterine fibroids or less severe outcomes would fall considerably lower. These projections hinge almost entirely on the upcoming Daubert ruling and the first bellwether verdicts. Anyone promising a specific payout at this stage is getting ahead of the evidence.
Attorney Fees and Costs
Virtually all hair relaxer attorneys work on contingency, meaning you pay nothing upfront and the attorney collects a percentage of your recovery only if you win or settle. The standard contingency fee in personal injury litigation runs around 33%, though mass tort cases range from 25% to 40% depending on the firm. Beyond the attorney’s percentage, litigation costs such as filing fees, expert witness fees, and medical record retrieval come out of the recovery as well. In most arrangements, costs are advanced by the firm and deducted from your share of the settlement. Ask about this explicitly during your initial consultation, because whether costs are deducted before or after the attorney’s percentage can meaningfully change your take-home amount.
Taxes and Government Benefits
Under federal tax law, damages received for personal physical injuries or physical sickness are excluded from your gross income.3Office of the Law Revision Counsel. 26 USC 104 – Compensation for Injuries or Sickness The portion of a hair relaxer settlement compensating you for your cancer, including medical expenses, pain and suffering, and lost wages tied to the physical injury, is not taxable. The IRS has consistently held that compensatory damages received on account of a personal physical injury, including lost wages, are excludable from gross income.4Internal Revenue Service. Tax Implications of Settlements and Judgments Two exceptions to watch for: punitive damages are fully taxable regardless of the underlying injury, and any interest earned on your settlement funds is taxable as ordinary income.
If you receive Supplemental Security Income or Medicaid, a settlement can threaten your eligibility even though it is not taxable. SSI counts a settlement as a resource, and the resource limit is $2,000 for an individual or $3,000 for a couple.5Social Security Administration. Understanding Supplemental Security Income Resources Exceeding that limit in any month makes you ineligible for that month. Medicaid works similarly in states that have not expanded coverage, where many maintain a $2,000 asset limit, and a lump-sum settlement that pushes you over that threshold can cost you health coverage at exactly the moment you need it most.
You are required to report a settlement to your state Medicaid agency and to Social Security if you receive SSI. Failing to report can lead to repayment demands or termination of benefits. One protective option is a special needs trust, which holds settlement funds for a person with disabilities without counting those funds as a resource for benefits eligibility. The tradeoff is that any money left in the trust after your death must first reimburse Medicaid for services it paid on your behalf. Discuss this with a benefits-planning attorney before you receive any settlement funds, not after the money has hit your bank account and triggered reporting issues.